Matthew W. Kemp

Matthew W. Kemp

Auto-generated profile, based on publicly available information

Matthew W. Kemp

Centre for Perinatal and Neonatal Medicine, Tohoku University Hospital, Sendai, Japan

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
MKMatthew W. Kemp
Matthew W. Kemp
MSMasatoshi Saito
Masatoshi Saito
ASAugusto F Schmidt
Augusto F Schmidt
HUHaruo Usuda
Haruo Usuda
SWShimpei Watanabe
Shimpei Watanabe
AJAlan H Jobe
Alan H Jobe

24 September 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YTYuki Takahashi
Yuki Takahashi
MSMasatoshi Saito
Masatoshi Saito
HUHaruo Usuda
Haruo Usuda
TTTsukasa Takahashi
Tsukasa Takahashi
SWShimpei Watanabe
Shimpei Watanabe
MKMatthew W. Kemp
Matthew W. Kemp
Background: Intraamniotic inflammation is associated with up to 40% of preterm births, most notably in deliveries occurring prior to 32 weeks’ gestation. Despite this, there are few treatment options allowing the prevention of preterm birth and associated fetal injury. Recent studies have shown that the small, non-competitive allosteric interleukin (IL)-1 receptor inhibitor, rytvela, may be of use in resolving inflammation associated with preterm birth (PTB) and fetal injury. We aimed to use an extremely preterm sheep model of chorioamnionitis to investigate the anti-inflammatory efficacy of rytvela in response to established intra-amniotic (IA) lipopolysaccharide (LPS) exposure. We hypothesized that rytvela would reduce LPS-induced IA inflammation in amniotic fluid (AF) and fetal tissues. Methods: Sheep with a single fetus at 95 days gestation (estimated fetal weight 1.0 kg) had surgery to place fetal jugular and IA catheters. Animals were recovered for 48 hours before being randomized to either: i) IA administration of 2 ml saline 24 hours before 2 ml IA and 2 ml fetal intravenous (IV) administration of saline (Saline Group, n = 7); ii) IA administration of 10 mg LPS in 2 ml saline 24 hours before 2 ml IA and 2 ml fetal IV saline (LPS Group, n = 10); 3) IA administration of 10 mg LPS in 2 ml saline 24 hours before 0.3 mg/fetal kg IA and 1 mg/fetal kg fetal IV rytvela in 2 ml saline, respectively (LPS + rytvela Group, n = 7). Serial AF samples were collected for 120 h. Inflammatory responses were characterized by quantitative polymerase chain reaction (qPCR), histology, fluorescent immunohistochemistry, enzyme-linked inmmunosorbent assay (ELISA), fluorescent western blotting and blood chemistry analysis. Results: LPS-treated animals had endotoxin and AF monocyte chemoattractant protein (MCP)-1 concentrations that were significantly higher at 24 hours (immediately prior to rytvela administration) relative to values from Saline Group animals. Following rytvela administration, the average MCP-1 concentrations in the AF were significantly lower in the LPS + rytvela Group relative to in the LPS Group. In delivery samples, the expression of IL-1β in fetal skin was significantly lower in the LPS + rytvela Group compared to the LPS Group. Conclusion: A single dose of rytvela was associated with partial, modest inhibition in the expression of a panel of cytokines/chemokines in fetal tissues undergoing an active inflammatory response.

17 February 2020 in Pediatric Research
Verified
Journal Article
Open access
PDF file
NHNoah H. Hillman
Noah H. Hillman
LALeenah Abugisisa
Leenah Abugisisa
EREmily Royse
Emily Royse
EFErin Fee
Erin Fee
MKMatthew W. Kemp
Matthew W. Kemp
AJAlan H Jobe
Alan H Jobe
Background The addition of budesonide (Bud) 0.25 mg/kg to surfactant decreased the lung and systemic responses to mechanical ventilation in preterm sheep and the rates and severity of bronchopulmonary dysplasia (BPD) in preterm infants. We hypothesized that lower budesonide concentrations in surfactant will decrease injury while decreasing systemic corticosteroid exposure. Methods Preterm lambs received either (1) protective tidal volume (VT) ventilation with surfactant from birth or (2) injurious VT ventilation for 15 min and then surfactant treatment. Lambs were further assigned to surfactant mixed with (i) Saline, (ii) Bud 0.25 mg/kg, (iii) Bud 0.1 mg/kg, or (iv) Bud 0.04 mg/kg. All lambs were then ventilated with protective VT for 6 h. Results Plasma Bud levels were proportional to the dose received and decreased throughout ventilation. In both protective and injurious VT ventilation, <4% of Bud remained in the lung at 6 h. Some of the improvements in physiology and markers of injury with Bud 0.25 mg/kg were also found with 0.1 mg/kg, whereas 0.04 mg/kg had only minimal effects. Conclusions Lower doses of Bud were less effective at decreasing lung and systemic inflammation from mechanical ventilation. The plasma Bud levels were proportional to dose given and the majority left the lung.

12 August 2013 in Journal of Higher Education Policy and Management
Verified
Journal Article
Closed access
MKMatthew W. Kemp
Matthew W. Kemp
TMTimothy J. Molloy
Timothy J. Molloy
MPMarina Pajic
Marina Pajic
Elaine Stella ChapmanElaine Stella Chapman
Elaine Stella Chapman
Little attention has been paid to the scholarship of doctoral education in the biomedical sciences, hindering the formulation of research-informed improvements to this important area of higher education. We present an analysis of interview data from Australian PhD students and suggest that relationships between students and their ‘non-supervisor’ peers are critical to student learning.

15 April 2020 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
CHCathelijne Heymans
Cathelijne Heymans
ILIlse de Lange
Ilse de Lange
MHMatthias Christian Hütten
Matthias Christian Hütten
KLKaatje Lenaerts
Kaatje Lenaerts
NRNadine J. E. de Ruijter
Nadine J. E. de Ruijter
Tim WolfsTim Wolfs
Tim Wolfs
Corrigendum: Chronic Intra-Uterine Ureaplasma parvum Infection Induces Injury of the Enteric Nervous System in Ovine Fetuses

2 January 2024 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Open access
HIHideyuki Ikeda
Hideyuki Ikeda
SWShimpei Watanabe
Shimpei Watanabe
SSShinichi Sato
Shinichi Sato
EFErin L. Fee
Erin L. Fee
SCSean William David Carter
Sean William David Carter
HUHaruo Usuda
Haruo Usuda
Extremely preterm infants have low Nuclear Receptor (NR) expression in their developing hepatobiliary systems, as they rely on the placenta and maternal liver for compensation. NRs play a crucial role in detoxification and the elimination of both endogenous and xenobiotic substances by regulating key genes encoding specific proteins. In this study, we utilized an Artificial Placenta Therapy (APT) platform to examine the liver tissue expression of NRs of extremely preterm ovine fetuses. This fetal model, resembling a "knockout placenta," lacks placental and maternal support, while maintaining a healthy extrauterine survival. Six ovine fetuses at 95 ± 1 d gestational age (GA; term = ∼150 d)/∼600 g delivery weight were maintained on an APT platform for a period of 120 h (APT Group). Six age-matched, in utero control fetuses were delivered at 99-100 d GA (Control Group). Fetal liver tissue samples and blood samples were collected at delivery from both groups and assessed mRNA expression of NRs and target transporters involved in the hepatobiliary transport system using quantitative PCR. Data were tested for group differences with ANOVA (p < .05 deemed significant). mRNA expression of NRs was identified in both the placenta and the extremely preterm ovine fetal liver. The expression of HNF4α, LRH1, LXR, ESR1, PXR, CAR, and PPARα/γ were significantly elevated in the liver of the APT Group compared to the Control Group. Moreover, target transporters NTCP, OATP1B3, BSEP, and MRP4 were upregulated, whereas MRP2 and MRP3 were unchanged. Although there was no evidence of liver necrosis or apoptotic changes histologically, there was an impact in the fetal liver of the ATP group at the tissue level with a significant increase in TNFα mRNA, a cytokine involved in liver inflammation, and blood elevation of transaminases. A number of NRs in the fetal liver were significantly upregulated after loss of placental-maternal support. However, the expression of target transporter genes appeared to be insufficient to compensate role of the placenta and maternal liver and avoid fetal liver damage, potentially due to insufficient excretion of organic anions.